These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33806922)

  • 1. SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma.
    Klaus J; Palizzotto C; Zini E; Meli ML; Leo C; Egberink H; Zhao S; Hofmann-Lehmann R
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33806922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection in Dogs and Cats from Southern Germany and Northern Italy during the First Wave of the COVID-19 Pandemic.
    Klaus J; Zini E; Hartmann K; Egberink H; Kipar A; Bergmann M; Palizzotto C; Zhao S; Rossi F; Franco V; Porporato F; Hofmann-Lehmann R; Meli ML
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland.
    Klaus J; Meli ML; Willi B; Nadeau S; Beisel C; Stadler T; Eth Sars-CoV-Sequencing Team ; Egberink H; Zhao S; Lutz H; Riond B; Rösinger N; Stalder H; Renzullo S; Hofmann-Lehmann R
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
    Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
    Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease-19 pandemic.
    Adler JM; Weber C; Wernike K; Michelitsch A; Friedrich K; Trimpert J; Beer M; Kohn B; Osterrieder K; Müller E
    Zoonoses Public Health; 2022 Aug; 69(5):439-450. PubMed ID: 35238485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy.
    Spada E; Vitale F; Bruno F; Castelli G; Reale S; Perego R; Baggiani L; Proverbio D
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    Hancock TJ; Hickman P; Kazerooni N; Kennedy M; Kania SA; Dennis M; Szafranski N; Gerhold R; Su C; Masi T; Smith S; Sparer TE
    J Virol; 2022 Apr; 96(8):e0025022. PubMed ID: 35352999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats.
    van der Leij WJR; Broens EM; Hesselink JW; Schuurman N; Vernooij JCM; Egberink HF
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dynamics of neutralizing antibodies against SARS-CoV-2 in cats naturally exposed to virus reveals an increase in antibody activity after re-infection.
    Villanueva-Saz S; Martínez M; Rueda P; Bolea S; Pérez MD; Verde M; Yzuel A; Hurtado-Guerrero R; Pardo J; Santiago L; Fernández A; Arias M
    Vet Res Commun; 2023 Dec; 47(4):2179-2184. PubMed ID: 36918467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats.
    Park ES; Kuroda Y; Uda A; Kaku Y; Okutani A; Hotta A; Tatemoto K; Ishijima K; Inoue Y; Harada M; Ami Y; Shirakura M; Watanabe S; Suzuki Y; Harada T; Ainai A; Shiwa N; Sakai Y; Iwata-Yoshikawa N; Nagata N; Suzuki T; Hasegawa H; Maeda K
    Sci Rep; 2024 Sep; 14(1):21815. PubMed ID: 39294189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study.
    Griffante G; Chandel S; Ferrante D; Caneparo V; Capello D; Bettio V; Borgogna C; Aleni C; Esposito S; Sarro A; Vasile A; Comba M; Testa T; Cotrupi G; De Andrea M; Bortoluzzi S; Gariglio M
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.
    Gütlin Y; Albertos Torres D; Gensch A; Schlotterbeck AK; Stöger L; Heller S; Infanti L; Barut GT; Thiel V; Leuzinger K; Hirsch HH; Buser A; Egli A
    Swiss Med Wkly; 2024 Jul; 154():3408. PubMed ID: 39137369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of diagnostic performances of different serological tests for SARS-CoV-2 antibody detection in cats and dogs.
    Ratti G; Lelli D; Moreno A; Stranieri A; Trogu T; Giordano A; Grassi A; Luzzago C; Decaro N; Paltrinieri S; Lauzi S
    Transbound Emerg Dis; 2022 Nov; 69(6):3530-3539. PubMed ID: 36183165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
    Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 in Domestic UK Cats from Alpha to Omicron: Swab Surveillance and Case Reports.
    Jones S; Tyson GB; Orton RJ; Smollett K; Manna F; Kwok K; Suárez NM; Logan N; McDonald M; Bowie A; Filipe ADS; Willett BJ; Weir W; Hosie MJ
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.